FRONTOTEMPORAL DEMENTIA
Clinical trials for FRONTOTEMPORAL DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new FRONTOTEMPORAL DEMENTIA trials appear
Sign up with your email to follow new studies for FRONTOTEMPORAL DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising dementia drug trial halted early – what happened?
Disease control TerminatedThis study tested a drug called AL001 in people who have a gene mutation that puts them at risk for or already causes frontotemporal dementia (FTD). The goal was to see if AL001 could slow down the disease. The trial was stopped early, so we don't have final results on whether it…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: PHASE3 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Experimental drug aims to curb disinhibition in dementia patients
Symptom relief TerminatedThis study tested a drug called AVP-786 to see if it could safely reduce disinhibition—impulsive or inappropriate behavior—in people with neurodegenerative disorders like Alzheimer's or frontotemporal dementia. The trial planned to include many participants but was terminated ear…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 23, 2026 19:18 UTC
-
New drug aimed at treating apathy in dementia patients tested
Symptom relief TerminatedThis study tested a drug called CVL-871 to see if it is safe and can help reduce apathy (lack of motivation or interest) in people with dementia. The trial included 41 participants with mild to moderate dementia and clinically significant apathy. The main goal was to check for si…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 22, 2026 12:03 UTC
-
Touchscreen device aims to give voice to dementia patients
Symptom relief TerminatedThis study tested a personalized touchscreen device (My PATI) to help people with Alzheimer's or related dementias communicate their care preferences. The goal was to improve quality of life for both patients and their caregivers. The study was terminated early, so results are li…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: Florida International University • Aim: Symptom relief
Last updated Jun 18, 2026 11:49 UTC